| Comparing Two Training Methods for Opioid Wizard (NCT04867382) | HealthPartners Institute | 2021-04-09 |
| Optimization of NIBS for Treatment of Addiction (NCT04379115) | Case Western Reserve University | 2021-04-04 |
| Evaluating the Efficacy of a Digital Platform to Deliver Comprehensive Treatment for Opioid Use Disorder (NCT05529225) | Boulder Care | 2021-04-01 |
| Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder (NCT04797962) | Denver Health and Hospital Authority | 2021-03-30 |
| Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal (NCT04731935) | Spark Biomedical, Inc. | 2021-03-18 |
| Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (NCT04762537) | New York State Psychiatric Institute | 2021-03-16 |
| Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections (NCT04677114) | Laura Fanucchi | 2021-03-16 |
| Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans (NCT04360681) | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 2021-03-09 |
| SMART Trial: Intrapersonal and Interpersonal Stigma Reduction (NCT04693416) | University of Tennessee | 2021-03-08 |
| Opioid Treatment and Peer Recovery Support (NCT04978168) | Brown University | 2021-03-02 |
| Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase) (NCT04278586) | Cambridge Health Alliance | 2021-02-15 |
| Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder (NCT04262193) | Wayne State University | 2021-02-01 |
| Pharmacokinetic Study of Vivitrol in Healthy Participants (NCT04716881) | Go Medical Industries Pty Ltd | 2021-01-25 |
| Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine (NCT04161066) | University of Wisconsin, Madison | 2021-01-13 |
| Collaboration Leading to Addiction Treatment and Recovery From Other Stresses (NCT04559893) | RAND | 2021-01-08 |
| Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Opioid Use Disorders ("EXPO" Pilot Trial) (NCT04736550) | Case Western Reserve University | 2021-01-08 |
| Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults (NCT04219540) | NYU Langone Health | 2021-01-07 |
| Virginia Opioid Treatment-Emergency Department (NCT04523792) | Virginia Commonwealth University | 2021-01-01 |
| Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure (NCT05463367) | Northwestern University | 2021-01-01 |
| Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use Disorder (NCT04169360) | University of Maryland, Baltimore | 2021-01-01 |
| Use of Transcranial Magnetic Stimulation to Reduce Craving for Individuals With Opioid Use Disorder Taking Buprenorphine (NCT03653169) | Brigham and Women's Hospital | 2021-01-01 |
| Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction (NCT03394911) | Bubba Nicholson | 2020-12-31 |
| Coaching for HCV and HIV (NCT04314414) | Boston Medical Center | 2020-12-20 |
| Promoting Caregiver-child Attachment and Recovery Through Early Intervention (pCARE): A Pilot Randomized Control Trial (NCT04675099) | Baystate Medical Center | 2020-12-18 |
| Ketamine for the Treatment of Opioid Use Disorder and Depression (NCT04177706) | Medical University of South Carolina | 2020-12-17 |
| Kentucky Women's Justice Community Opioid Innovation Network (NCT04069624) | Michele Staton | 2020-12-17 |
| The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions (NCT04245423) | University of Pennsylvania | 2020-12-15 |
| Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder (NCT04352166) | Frances R Levin | 2020-12-15 |
| CBT4CBT-Buprenorphine + Recovery Coach for Office-based Buprenorphine (NCT04824404) | Prisma Health-Upstate | 2020-12-15 |
| Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study (NCT04656899) | Washington State University | 2020-12-06 |
| Substance Use Treatment and Recovery Team (START) (NCT04314648) | RAND | 2020-12-04 |
| Emergency Department Outcomes for Patients With Opioid Use Disorder (NCT04289363) | NYU Langone Health | 2020-11-25 |
| Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder (NCT04287062) | Johns Hopkins University | 2020-11-20 |
| Collaborating to Heal Addiction and Mental Health in Primary Care (NCT04600414) | University of Washington | 2020-11-16 |
| Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders (NCT04556552) | Emory University | 2020-11-13 |
| Strategies to Reduce Addiction Stigma Among Health Professionals (NCT05127707) | Johns Hopkins Bloomberg School of Public Health | 2020-11-13 |
| A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder (NCT04375033) | VA Office of Research and Development | 2020-11-03 |
| Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine (NCT04611659) | Meharry Medical College | 2020-11-01 |
| Oral Cannabidiol for Opioid Withdrawal (NCT04238754) | Johns Hopkins University | 2020-11-01 |
| Buprenorphine Loading in the Emergency Department (NCT04283500) | NYU Langone Health | 2020-11-01 |
| Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail (NCT04408313) | Friends Research Institute, Inc. | 2020-10-28 |
| Peer-Delivered Behavioral Activation for Methadone Adherence - Pilot Phase (NCT04248933) | University of Maryland, College Park | 2020-10-09 |
| Clinical Trials of Multivalent Opioid Vaccine Components (NCT04458545) | New York State Psychiatric Institute | 2020-10-08 |
| Digital Health Intervention to Support Opioid Use Disorder Treatment (NCT03842384) | Rhode Island Hospital | 2020-10-01 |
| Pain and Opioid Management in Older Adults (NCT05037682) | University of Oklahoma | 2020-09-30 |
| STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy (NCT04527926) | University of Pittsburgh | 2020-09-30 |
| Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients (NCT04650386) | Public Health Management Corporation | 2020-09-21 |
| An Observational Study of Environmental and Socioeconomic Factors in Opioid Recovery - Long Term (NCT04577144) | Indivior Inc. | 2020-09-20 |
| reSET-O RCT (Randomized Controlled Trial) (NCT04129580) | Milton S. Hershey Medical Center | 2020-09-15 |
| Intervention to Facilitate MMT/HIV Service Decentralization in Vietnam (NCT04798534) | University of California, Los Angeles | 2020-08-28 |
| PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Opioid-Naive Population (NCT04601493) | University of Minnesota | 2020-08-26 |
| PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Primary Care Providers (NCT04601506) | University of Minnesota | 2020-08-26 |
| PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Current Opioid-User Population (NCT04601480) | University of Minnesota | 2020-08-26 |
| User Acceptability of a Device-Based Opioid Overdose Intervention (NCT04530591) | University of Pennsylvania | 2020-08-25 |
| Project STAMINA (Syringe Service Telemedicine Access for Medication-assisted Intervention Through NAvigation) (NCT04575324) | Chestnut Health Systems | 2020-08-24 |
| Coordinating Opioid Use Treatment Through Medical Management With Infection Treatment (Project COMMIT) (NCT04180020) | Yale University | 2020-08-18 |
| SMART Effectiveness Trial (NCT04464421) | Karen Derefinko, PhD | 2020-08-17 |
| BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control (NCT04365465) | Grace Lim, MD, MS | 2020-08-17 |
| Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes (NCT04433975) | University of Michigan | 2020-08-14 |
| Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC) (NCT04427202) | University of Chicago | 2020-08-14 |
| Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment (NCT04308694) | Friends Research Institute, Inc. | 2020-08-06 |
| Patient Decision Aid for Opioid Use Disorder (NCT03568552) | University of California, Los Angeles | 2020-08-03 |
| Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine (NCT04192370) | Brigham and Women's Hospital | 2020-08-03 |
| Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder (NCT04535583) | Dartmouth-Hitchcock Medical Center | 2020-07-23 |
| Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder (NCT04257214) | Philadelphia College of Osteopathic Medicine | 2020-07-15 |
| Emergency Department-Initiated Buprenorphine Validation Network Trial (NCT04225598) | Yale University | 2020-07-08 |
| mHealth for Patient Self-Management of Opioid Use Disorder (NCT03633929) | Biomedical Development Corporation | 2020-07-08 |
| Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid (NCT04632238) | NYU Langone Health | 2020-07-01 |
| Mindfulness-Based Relapse Prevention for Opioid and Alcohol Use Disorders (NCT04278352) | Clemson University | 2020-07-01 |
| Usability Testing for the Reward-based Technology to Improve OUD Treatment (NCT05159362) | Q2i, LLC | 2020-07-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants (NCT04448561) | Astellas Pharma Global Development, Inc. | 2020-06-30 |
| A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder (NCT04447287) | Astellas Pharma Global Development, Inc. | 2020-06-29 |
| Treatment of Pregnant Women With OUD (NCT04240392) | Yale University | 2020-06-18 |
| Rural MOUD Telemedicine in Primary Care Phase 1 (NCT04418453) | University of California, Los Angeles | 2020-06-01 |
| Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder (NCT04275258) | University of Washington | 2020-06-01 |
| Subthreshold Opioid Use Disorder Prevention (STOP) Trial (NCT04218201) | NYU Langone Health | 2020-03-25 |
| Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder (NCT06359340) | Public Health Management Corporation | 2020-03-13 |
| Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3 (NCT04268173) | University of Wisconsin, Madison | 2020-03-12 |
| Pilot Research on Opioid Use Disorder (NCT04244227) | Theranova, L.L.C. | 2020-03-10 |
| Obstetric Pain Management for Women With Opioid Use Disorder (QUEST) (NCT04308655) | University of Pittsburgh | 2020-03-06 |
| Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women (NCT04212065) | Ohio State University | 2020-02-21 |
| Technology for MAT in Primary Care - Phase 1 (NCT05006846) | Q2i, LLC | 2020-02-18 |
| The Youth Opioid Recovery Support (YORS) Intervention (NCT04173416) | Potomac Health Foundations | 2020-02-17 |
| Contingency Management to Enhance Office-Based Buprenorphine Treatment (NCT04024059) | Johns Hopkins University | 2020-01-31 |
| Minds and Mentors Program (MiMP)- R61 (NCT04233671) | University of Alabama, Tuscaloosa | 2020-01-28 |
| Increasing MAT Engagement With Financial Incentives (NCT04585399) | Rowan University | 2020-01-27 |
| Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder (NCT04234516) | New York State Psychiatric Institute | 2020-01-20 |
| The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis (NCT04033562) | WellSpan Health | 2020-01-15 |
| The Effect of Chronic Pain on Delay Discounting in Methadone Patients (NCT04473950) | University of California, San Francisco | 2020-01-08 |
| Effectiveness of a CBT-based mHealth Intervention Targeting MOUD Retention, Adherence, and Opioid Use (NCT04808479) | University of California, Los Angeles | 2019-12-10 |
| Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs) (NCT04197921) | InSightec | 2019-11-27 |
| Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal (NCT04075214) | Spark Biomedical, Inc. | 2019-11-19 |
| CoMBAT Opioid Use Disorder: A Combined Medication and Behavioral Activation Treatment for People Living With Opioid Use Disorder (NCT04240093) | Brown University | 2019-11-15 |
| Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD (NCT03658642) | Yale University | 2019-11-15 |
| Efficacy And Safety Of An Innovative Treatment Of Opiate Use Disorders (NCT04340622) | MindLight, LLC | 2019-11-12 |
| Prolonged Exposure Therapy for PTSD and Opioid Use Disorder (NCT04104022) | University of Vermont | 2019-11-08 |
| Facilitating the Implementation of Interim Methadone to Increase Treatment Access (NCT04188977) | Friends Research Institute, Inc. | 2019-11-01 |
| Effect of Preoperative Counseling on Postoperative Opioid Use Following Knee Arthroscopy. (NCT04083209) | Indiana University | 2019-10-15 |
| Transcranial Magnetic Stimulation (rTMS) as a Tool to Decrease Pain and Improve Functioning (NCT03821337) | VA Office of Research and Development | 2019-10-11 |
| Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms (NCT04091009) | Massachusetts General Hospital | 2019-10-01 |